HILT in Greater Trochanteric Pain Syndrome
ConditionGreater Trochanteric Pain Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorAnkara Etlik City Hospital
About this trial
Greater Trochanteric Pain Syndrome (GTPS) is a common cause of lateral hip pain that can significantly impair daily activities and quality of life. Conservative treatments, including physical therapy modalities and injections, are considered first-line management.
High-Intensity Laser Therapy (HILT) is a non-invasive modality with greater tissue penetration compared to low-level laser therapy and has shown promising results in musculoskeletal disorders; however, evidence in GTPS is limited.
This study aims to evaluate the efficacy of HILT compared with a sham intervention in patients with GTPS, focusing on pain intensity, functional status, and quality of life.
Eligibility criteria
Qualifiers
Adults aged 18 to 80 years
Patients diagnosed with Greater Trochanteric Pain Syndrome (GTPS) based on clinical examination
Presence of symptoms for at least 3 months
Pain intensity ≥4 on the Visual Analog Scale (VAS)
Disqualifiers
Hip fracture, tumor, infection, or advanced osteoarthritis
Contraindications to high-intensity laser therapy (e.g., pacemaker, pregnancy, coagulation disorders, anticoagulant therapy, neoplasia, history of epilepsy)
Contraindications to physical activity (e.g., ischemic heart disease, arrhythmia, uncontrolled hypertension, heart failure, severe respiratory insufficiency)
Peripheral vascular disorders (e.g., thrombophlebitis, thrombosis, lymphedema)
Trial design
Treatments tested in this trial
- High-Intensity Laser Therapy (HILT)
- Sham Laser
Treatment groups
64 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov